Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Fennec Pharmaceuticals (FENC) Other Gross PP&E Adjustments (2022 - 2025)

Fennec Pharmaceuticals filings provide 4 years of Other Gross PP&E Adjustments readings, the most recent being -$22000.0 for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 42.11% to -$22000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$22000.0, a 42.11% increase, with the full-year FY2025 number at -$22000.0, up 42.11% from a year prior.
  • Other Gross PP&E Adjustments hit -$22000.0 in Q4 2025 for Fennec Pharmaceuticals, up from -$38000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$22000.0 in Q4 2025 to a low of -$77000.0 in Q4 2022.
  • Median Other Gross PP&E Adjustments over the past 4 years was -$38000.0 (2024), compared with a mean of -$47800.0.
  • Biggest five-year swings in Other Gross PP&E Adjustments: increased 5.19% in 2023 and later skyrocketed 47.95% in 2024.
  • Fennec Pharmaceuticals' Other Gross PP&E Adjustments stood at -$77000.0 in 2022, then increased by 5.19% to -$73000.0 in 2023, then skyrocketed by 47.95% to -$38000.0 in 2024, then soared by 42.11% to -$22000.0 in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$22000.0 (Q4 2025), -$38000.0 (Q4 2024), and -$73000.0 (Q4 2023) per Business Quant data.